Veterinary CRO And CDMO Market Size & Share, By Animal Type (Companion, Livestock), Service Type (Discovery, Development), Application - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 14345| Published Date: Apr-2025| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Veterinary CRO & CDMO Market size is predicted to reach USD 15.74 billion by 2034, up from USD 6.77 billion in 2024, reflecting a CAGR of over 8.8% during the forecast period from 2025 to 2034. The industry revenue for 2025 is projected to be USD 7.31 billion.

Base Year Value (2024)
USD 6.77 billion
CAGR (2025-2034)
8.8%
Forecast Year Value (2034)
USD 15.74 billion
Historical Data Period
2021-2034
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Veterinary CRO & CDMO Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Market Dynamics

Market Growth Drivers and Industry Trends

Growth Drivers & Opportunities The Veterinary CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organizations) market is witnessing significant growth, driven by an increasing demand for veterinary research and the rising importance of animal health awareness. As pet ownership continues to rise globally, there is a growing need for innovative veterinary products, including medications and vaccines, to ensure the health and well-being of animals. This surge in demand fosters an environment ripe for both CROs and CDMOs, as they provide essential services that support clinical trials, regulatory compliance, and product development. Another key growth driver in this market is the increasing investment in animal health research and development. Pharmaceutical companies are allocating more resources towards R&D activities, which is subsequently benefiting CROs and CDMOs. These organizations play a vital role in helping companies navigate through the complex regulatory landscape, allowing for faster and more efficient product development timelines. Additionally, the trend towards outsourcing various stages of drug development is escalating, as companies seek to improve operational efficiency and manage costs, further propelling the growth of veterinary CROs and CDMOs. Moreover, advancements in technology are presenting new opportunities within the market. Innovations such as telemedicine, wearable health monitoring devices for animals, and advanced data analytics are transforming the way veterinary care is delivered and monitored. CROs and CDMOs can leverage these emerging technologies to enhance their service offerings, streamline clinical processes, and ultimately improve the outcomes of veterinary products. Collaborations between veterinary organizations and tech companies are becoming more common, creating synergies that can accelerate the development of new therapies. Industry Restraints Despite its promising growth trajectory, the veterinary CRO and CDMO market faces several challenges that could hinder its expansion. One of the primary restraints is the strict regulatory environment governing animal health products. Navigating through the intricate maze of regulations can be time-consuming and costly for CROs and CDMOs, as they must ensure compliance with various national and international standards. This complexity can deter potential new entrants into the market and slow down the overall pace of innovation. Additionally, the veterinary market is characterized by a relatively small client base compared to the human healthcare sector. This smaller market can limit the scale and financial resources available to CROs and CDMOs. Furthermore, the reliance on a limited number of large pharmaceutical companies can create vulnerabilities, as shifts in their business strategies or priorities may directly impact the demand for contracting organizations. Economic fluctuations can also affect funding for veterinary research, potentially slowing down investment in new projects. Moreover, labor shortages and the need for skilled professionals in veterinary medicine and research fields pose another significant challenge. The growing demand for veterinary CROs and CDMOs may not be met due to issues related to workforce availability and training. This gap can restrict the ability of these organizations to respond swiftly to the needs of the market, thereby affecting their sustainability and growth prospects. As the industry evolves, addressing these workforce-related challenges will be crucial for maintaining the momentum of growth in the veterinary CRO and CDMO sectors.

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Veterinary CRO & CDMO Market
Largest Region
North America
XX% Market Share in 2024
North America The North American Veterinary CRO & CDMO market is predominantly driven by the advanced healthcare infrastructure and significant investment in research and development. The United States stands out as the largest market within this region, fueled by a strong presence of both established and emerging veterinary pharmaceutical companies. In particular, states with major biotech clusters, such as California and Massachusetts, are expected to show substantial growth. Canada is also witnessing an increased focus on veterinary services and related research, with ongoing support from government initiatives aimed at improving animal healthcare. Both countries benefit from a high level of consumer awareness regarding pet health, driving demand for innovative veterinary services and products. Asia Pacific Asia Pacific is emerging as a dynamic region for the Veterinary CRO & CDMO market, with countries like China and Japan leading the charge. China, with its rapidly growing pet ownership and burgeoning veterinary sector, is expected to exhibit the most significant growth in the coming years. The country’s focus on improvements in livestock health and food safety is boosting the demand for veterinary CROs and CDMOs. Japan maintains a robust market due to its advanced technology in healthcare and a strong regulatory framework, supporting high-quality services and product development. South Korea is also gaining traction, as the government's emphasis on animal welfare and healthcare fuels market expansion. Europe In Europe, the Veterinary CRO & CDMO market is characterized by a strong regulatory environment and an established veterinary infrastructure. The United Kingdom is a key player, thanks to its leading veterinary research institutions and a high demand for innovative veterinary medicines associated with increasing pet ownership and livestock management. Germany follows closely, with a well-developed pharmaceutical industry that is investing heavily in the veterinary sector. France is also noteworthy, offering a range of services and products that cater to both companion and farm animals. The overall European market is poised for gradual growth, driven by increased awareness regarding animal health and welfare across the region, particularly as pet ownership continues to rise.
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Animal Type The Veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) market is significantly influenced by the animal type segment, which primarily includes companion animals, livestock, and other animals. The companion animal sector, encompassing pets like dogs and cats, demonstrates robust growth driven by increasing pet ownership and heightened awareness regarding animal health. This segment is expected to capture a large market size as pet owners prioritize advanced veterinary care and preventive treatments. The livestock sector, though traditionally slower-growing, is witnessing increasing investments in animal health products driven by the rise in demand for meat and dairy, enhancing its overall growth potential. Moreover, the small but notable segment of other animals, including exotic pets and wildlife, is also projected to grow, albeit at a slower pace, as awareness regarding wildlife health management increases. Service Type Within the service type segment, the offerings are categorized into preclinical studies, clinical trials, laboratory services, and consulting services. Preclinical studies hold a significant share due to their foundational role in drug development, catering to both companion and livestock animals while aligning with stringent regulatory requirements. Clinical trials, driven by the necessity for new veterinary medicine approvals, are also expected to show considerable growth, particularly as the demand for innovative treatments rises. Laboratory services, encompassing a range of diagnostic and testing services, continue to gain traction, reflecting an increased focus on preventative care and real-time health monitoring. Consulting services are emerging as a vital component, particularly for companies navigating complex regulatory landscapes, thereby contributing to the overall market expansion. Application The application segment of the Veterinary CRO and CDMO market is diversified, spanning therapeutic, diagnostic, and preventive applications. The therapeutic application segment, which includes the development of pharmaceuticals and biologics for treating various animal diseases, is anticipated to account for a significant market share, reflecting ongoing advancements in veterinary medicine. The diagnostic application segment is witnessing rapid growth, fueled by the rising demand for diagnostic tools and tests that enable early disease detection and management in both companion and livestock animals. Preventive applications, focusing on vaccines and preventive health initiatives, are also showing positive trends as pet owners and farmers increasingly prioritize preventive care measures to enhance animal welfare and productivity. This multifaceted growth across applications highlights a holistic approach to animal health management, offering a broad spectrum of opportunities in the veterinary CRO and CDMO landscape.
Segment Sub-Segment Largest Segment Fastest Growing
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

The Veterinary CRO & CDMO market is characterized by a significant competitive landscape driven by increasing demand for animal health innovations, regulatory complexities, and a growing focus on high-quality research and development. Key players in this market strive to offer comprehensive service portfolios, ranging from preclinical studies to commercial manufacturing, to meet the diverse needs of biopharmaceutical companies and veterinary drug developers. The market is also witnessing a rise in partnerships and collaborations aimed at enhancing service capabilities and expanding geographical reach. The emphasis on tailored solutions, advanced technologies, and the ability to navigate regulatory pathways are critical factors that differentiate companies in this space, creating both opportunities and challenges in a rapidly evolving environment. Top Market Players 1. Charles River Laboratories International, Inc. 2. Eligo Bioscience 3. WuXi AppTec 4. Labcorp Drug Development 5. Covance Inc. 6. Parexel International Corporation 7. Celerion 8. KCR 9. ICON plc 10. Syneos Health, Inc.
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Veterinary CRO & CDMO Market — Custom Segments

Segment Sub-Segment
No segment data available.

Veterinary CRO & CDMO Market — Custom TOC

Custom Chapter Chapter Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →